Editorial
Published on 02 Nov 2023
Editorial: Transcriptional regulation of macrophage function
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1321064
- 2,087 views
Type at least 3 characters
3,377 articles
Review
Published on 02 Nov 2023
The implication of neutrophil extracellular traps in nonalcoholic fatty liver disease
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1292679
- 6,628 views
- 13 citations
Original Research
Published on 31 Oct 2023
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1281687
- 6,840 views
- 3 citations
Original Research
Published on 30 Oct 2023
RIPK1 deficiency prevents thymic NK1.1 expression and subsequent iNKT cell development
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1103591
- 2,557 views
- 2 citations
Original Research
Published on 30 Oct 2023
Novel mediator in anaphylaxis: decreased levels of miR-375-3p in serum and within extracellular vesicles of patients
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1209874
- 3,268 views
- 6 citations
Original Research
Published on 27 Oct 2023
The slan antigen identifies the prototypical non-classical CD16+-monocytes in human blood
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1287656
- 3,646 views
- 1 citation
Original Research
Published on 27 Oct 2023
Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1252274
- 3,173 views
- 1 citation
Original Research
Published on 27 Oct 2023
Comprehensive analysis of necroptosis-related genes in renal ischemia-reperfusion injury
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1279603
- 3,161 views
- 3 citations
Clinical Trial
Published on 27 Oct 2023
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1255292
- 3,397 views
- 1 citation
Review
Published on 27 Oct 2023
Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1260859
- 11,332 views
- 28 citations
Review
Published on 26 Oct 2023
The role and mechanisms of macrophage polarization and hepatocyte pyroptosis in acute liver failure
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1279264
- 10,326 views
- 22 citations
Review
Published on 26 Oct 2023
RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1274654
- 6,638 views
- 6 citations
Original Research
Published on 26 Oct 2023
Multiple TLRs elicit alternative NLRP3 inflammasome activation in primary human monocytes independent of RIPK1 kinase activity
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1092799
- 4,354 views
- 11 citations
Review
Published on 26 Oct 2023
Chemokines, molecular drivers of thromboinflammation and immunothrombosis
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1276353
- 6,402 views
- 16 citations
Original Research
Published on 26 Oct 2023
Functional evaluation of complement factor I variants by immunoassays and SDS-PAGE
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1279612
- 2,672 views
- 2 citations
Original Research
Published on 25 Oct 2023
Qinhuo Shanggan oral solution resolves acute lung injury by down-regulating TLR4/NF-κB signaling cascade and inhibiting NLRP3 inflammasome activation
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1285550
- 3,455 views
- 8 citations